Your browser doesn't support javascript.
loading
Demography, patterns of care, and survival outcomes in patients with salivary duct carcinoma: an individual patient data analysis of 857 patients.
Giridhar, Prashanth; Venkatesulu, Bhanu Prasad; Yoo, Ryan; V, Pragathee; Rath, Goura K; Mallick, Supriya; Upadhyay, Ashishdutt; Chan, Dennis Pai.
Afiliación
  • Giridhar P; Department of Radiation Oncology, Tata Medical Centre,Varanasi.
  • Venkatesulu BP; Loyola University Chicago, Loyola University Medical Center &/or Edward Hines Jr., VA Hospital, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL 60153, USA.
  • Yoo R; Loyola University Chicago, Loyola University Medical Center &/or Edward Hines Jr., VA Hospital, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL 60153, USA.
  • V P; Department of Internal Medicine, Karpagam Faculty of Medical Sciences & Research, Coimbatore, Tamil Nadu, India.
  • Rath GK; Department of Radiation Oncology, All India institute of medical sciences, New Delhi, India.
  • Mallick S; Department of Radiation Oncology, All India institute of medical sciences, New Delhi, India.
  • Upadhyay A; Department of Biostatics, All India Institute of Medical Sciences, New Delhi, India.
  • Chan DP; Loyola University Chicago, Loyola University Medical Center &/or Edward Hines Jr., VA Hospital, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, IL 60153, USA.
Future Sci OA ; 8(4): FSO791, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35369277
Aim: Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. Methodology: A systematic search and individual patient data analysis of published cases of SDC was performed. SPSS v21 was used for statistical analysis. Results: Data of 857 patients available. Median overall survival (OS) and progression-free survival (PFS) of the entire cohort 42 months and 24 months. Nodal involvement, males, primary size >5 cm, androgen receptor (AR) negativity significantly worse OS. Patients with surgery had a favorable median PFS (p = 0.000) and OS (p = 0.077). Patients with adjuvant radiation had better PFS (30 vs 18 months; p = 0.077). Conclusion: SDC has modest survival. Surgery and adjuvant radiation should be advocated for all patients. AR expression appears prognostic for survival.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Future Sci OA Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Future Sci OA Año: 2022 Tipo del documento: Article